JPMED

Company Overview

Snapshot

Founded in February 1999 by Eitan Harduf and Doron Friedman, JPMED operates with 1–10 employees. The company focuses on developing and commercializing drug delivery systems for various medical applications.

Business overview

JPMED is a Health Tech & Life Sciences company specializing in the development of emulsion-based drug delivery systems. The company's core technology involves an oil-in-glycerin emulsion designed to dissolve essential oils without harsh chemicals. JPMED offers products such as Ear Comfort ear drops, Free Rinse mouthwash, Aphta Gel for canker sores, and Ora Protect for mucositis, serving the pharmaceutical and healthcare markets in Israel, Australia, and New Zealand.

Company Intelligence Q&A

What is JPMED's primary focus?

JPMED focuses on developing and commercializing emulsion-based drug delivery systems for ear and mouth treatments.

Which markets does JPMED currently serve?

JPMED's products are registered for human use in Israel and are in the process of registration in Australia and New Zealand.

Who are the founders of JPMED?

JPMED was co-founded by Eitan Harduf and Dr. Doron Friedman.

What types of products does JPMED offer?

JPMED offers products such as Ear Comfort ear drops, Free Rinse mouthwash, Aphta Gel for canker sores, and Ora Protect for mucositis.

What is the core technology behind JPMED's products?

JPMED utilizes a patent-protected oil-in-glycerin emulsion system for dissolving essential oils without the need for alcohol, harsh chemicals, or synthetic solvents.